CA2228503A1 - Emploi de griseofulvine pour inhiber la croissance des cancers - Google Patents
Emploi de griseofulvine pour inhiber la croissance des cancers Download PDFInfo
- Publication number
- CA2228503A1 CA2228503A1 CA002228503A CA2228503A CA2228503A1 CA 2228503 A1 CA2228503 A1 CA 2228503A1 CA 002228503 A CA002228503 A CA 002228503A CA 2228503 A CA2228503 A CA 2228503A CA 2228503 A1 CA2228503 A1 CA 2228503A1
- Authority
- CA
- Canada
- Prior art keywords
- agents
- composition according
- pharmaceutical composition
- griseofulvin
- tumors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
L'invention concerne une composition pharmaceutique pour le traitement de cancers ou de tumeurs chez les mammifères. Cette composition contient de la griséofulvine. On peut utiliser un agent chimiothérapeutique en association avec la griséofulvine, de même que des agents de potentialisation. La griséofulvine peut également être utilisée pour traiter des infections virales, seule, en association avec d'autres agents antiviraux ou avec un agent de potentialisation.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US183995P | 1995-08-03 | 1995-08-03 | |
US60/001,839 | 1995-08-03 | ||
US67418196A | 1996-07-16 | 1996-07-16 | |
US08/674,181 | 1996-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2228503A1 true CA2228503A1 (fr) | 1997-02-20 |
Family
ID=26669547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002228503A Abandoned CA2228503A1 (fr) | 1995-08-03 | 1996-07-30 | Emploi de griseofulvine pour inhiber la croissance des cancers |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0841914A2 (fr) |
JP (1) | JPH11511136A (fr) |
KR (1) | KR19990036137A (fr) |
AR (1) | AR003176A1 (fr) |
AU (1) | AU713031B2 (fr) |
BR (1) | BR9609920A (fr) |
CA (1) | CA2228503A1 (fr) |
CZ (1) | CZ30598A3 (fr) |
HU (1) | HUP9903506A3 (fr) |
IL (1) | IL123094A0 (fr) |
MX (1) | MX9800945A (fr) |
NO (1) | NO980420L (fr) |
PL (1) | PL324905A1 (fr) |
SK (1) | SK14298A3 (fr) |
TR (1) | TR199800244T2 (fr) |
WO (1) | WO1997005870A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
AU750313B2 (en) * | 1998-07-27 | 2002-07-18 | St. Jude Pharmaceuticals, Inc. | Chemically induced intracellular hyperthermia |
KR20010103655A (ko) * | 1998-11-09 | 2001-11-23 | 케네쓰 제이. 울코트 | 키메라 항-cd20항체를 이용한 순환성 종양세포와관련된 혈액학적 악성종양의 치료법 |
US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
US6462062B1 (en) | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6407105B1 (en) | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
ATE489080T1 (de) * | 2001-06-25 | 2010-12-15 | Ajinomoto Kk | Antitumorale mittel |
EP2008652A1 (fr) * | 2007-06-28 | 2008-12-31 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Analogues de la griséofulvine pour le traitement du cancer par inhibition du regroupement centrosomal |
EP2204367A1 (fr) * | 2008-12-22 | 2010-07-07 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Analogues de la griséofulvine pour le traitement du cancer par inhibition du regroupement centrosomal |
-
1996
- 1996-07-30 IL IL12309496A patent/IL123094A0/xx unknown
- 1996-07-30 TR TR1998/00244T patent/TR199800244T2/xx unknown
- 1996-07-30 SK SK142-98A patent/SK14298A3/sk unknown
- 1996-07-30 CZ CZ98305A patent/CZ30598A3/cs unknown
- 1996-07-30 HU HU9903506A patent/HUP9903506A3/hu unknown
- 1996-07-30 MX MX9800945A patent/MX9800945A/es unknown
- 1996-07-30 CA CA002228503A patent/CA2228503A1/fr not_active Abandoned
- 1996-07-30 WO PCT/US1996/012475 patent/WO1997005870A2/fr not_active Application Discontinuation
- 1996-07-30 JP JP9508495A patent/JPH11511136A/ja active Pending
- 1996-07-30 AU AU66834/96A patent/AU713031B2/en not_active Ceased
- 1996-07-30 EP EP96926807A patent/EP0841914A2/fr not_active Withdrawn
- 1996-07-30 KR KR1019980700805A patent/KR19990036137A/ko not_active Application Discontinuation
- 1996-07-30 BR BR9609920A patent/BR9609920A/pt unknown
- 1996-07-30 PL PL96324905A patent/PL324905A1/xx unknown
- 1996-08-02 AR ARP960103861A patent/AR003176A1/es not_active Application Discontinuation
-
1998
- 1998-01-30 NO NO980420A patent/NO980420L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0841914A2 (fr) | 1998-05-20 |
WO1997005870A3 (fr) | 1997-04-17 |
AU713031B2 (en) | 1999-11-18 |
BR9609920A (pt) | 1999-07-06 |
HUP9903506A2 (hu) | 2000-06-28 |
IL123094A0 (en) | 1998-09-24 |
HUP9903506A3 (en) | 2000-07-28 |
CZ30598A3 (cs) | 1998-06-17 |
NO980420L (no) | 1998-04-03 |
TR199800244T2 (xx) | 1998-09-21 |
MX9800945A (es) | 1998-04-30 |
SK14298A3 (en) | 1998-09-09 |
AU6683496A (en) | 1997-03-05 |
AR003176A1 (es) | 1998-07-08 |
PL324905A1 (en) | 1998-06-22 |
KR19990036137A (ko) | 1999-05-25 |
NO980420D0 (no) | 1998-01-30 |
WO1997005870A2 (fr) | 1997-02-20 |
JPH11511136A (ja) | 1999-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2228503A1 (fr) | Emploi de griseofulvine pour inhiber la croissance des cancers | |
AU714057B2 (en) | A pharmaceutical composition containing N-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers | |
AU711966B2 (en) | Use of fluconazole for inhibiting the growth of cancers | |
CA2217952C (fr) | Composition pharmaceutique contenant du benzimidazole pour inhiber le developpement des cancers | |
US5929099A (en) | Pharmaceutical composition for inhibiting the growth of cancers | |
CA2217953C (fr) | Composition pharmaceutique contenant des n-chlorophenylcarbamates et des n-chlorophenylthiocarbamates pour inhiber la croissance des virus et le developpement de cancers | |
MXPA98000998A (en) | Use of fluconazole to inhibit the growth of cance | |
EP0954309A1 (fr) | Traitement du vih et du cancer | |
US6110953A (en) | Pharmaceutical composition for inhibiting the growth of cancers | |
MXPA98000945A (en) | Use of griseofulvine to inhibit cancer growth | |
KR100424503B1 (ko) | 암전이억제제 | |
US5908855A (en) | Compositions for treating viral infections | |
US20010041678A1 (en) | Compositions and methods for treating cancer | |
MXPA97007808A (en) | A pharmaceutical composition containing n-chlorophenyl carbamates and n-chlorofinyl carbamates to inhibit the growth of viruses and cance | |
EP2931375B1 (fr) | Utilisation de combinaisons de substances actives pour induire une sénescence tumorale | |
AU2231500A (en) | A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers | |
MXPA97007810A (es) | Una composicion farmaceutica que contiene derivados de n-fosfonoglicina para inhibir el crecimientode virus y canceres | |
DE102005036655A1 (de) | Behandlung von Tumoren mit IKK-ß Inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |